IMPORTANT RISK INFORMATION PEDIATRIC SPLIT CATH® Indications for Use: The Medcomp® Pediatric Split Cath® is indicated for use in attaining Long-Term vascular access for Hemodialysis and Apheresis and in pediatric, adolescent, and adult patients as determined by the prescribing physician. It may be inser ted percutaneously and is primarily placed in the internal jugular vein. Alternate inser tion sites include the Subclavian and femoral vein. SPLIT CATH® III Indications for Use: The Medcomp® Split-Cath® III is indicated for use in attaining chronic (long-term) vascular access for hemodialysis and apheresis. It may be inser ted percutaneously and is ideally placed in the internal jugular vein of an adult patient. Alternate inser tion site includes the subclavian vein as required. SPLIT CATH® III TRANSLUMBAR Indications for Use: The Medcomp Split Cath® III Catheter is indicated for use in attaining long term vascular access for hemodialysis and apheresis in the adult patient. It may be inser ted percutaneously and is primarily placed in the internal jugular vein. Alternate inser tion sites include the subclavian vein and inferior vena cava as required. Catheters greater than 40cm are intended for femoral vein inser tion or inferior vena cava inser tion. Translumbar inser tion via inferior vena cava is indicated when all other access sites are identified as non-viable. PEDIATRIC SPLIT CATH®, SPLIT CATH® III, SPLIT CATH® III TRANSLUMBAR Contraindications: This catheter is intended for Long-Term vascular access only and should not be used for any purpose other than indicated in these instructions. SPLIT STREAM® Indications for Use: The Medcomp® Split-Stream® is indicated for use in attaining Long-Term vascular access for Hemodialysis and Apheresis. It may be inser ted percutaneously and is primarily placed in the internal jugular vein. Alternate inser tion sites include the subclavian vein. Catheters greater than 40cm are intended for femoral vein inser tion. Contraindications: This catheter is intended for Long-Term vascular access only and should NOT be used for any purpose other than indicated in these instructions. To maintain peak performance of the Split-Stream® extension set, it is recommended that the extension set be replaced every 6 months. TESIO® Indications for Use: The Medcomp® Tesio® Catheter is designed for long term hemodialysis and apheresis. It may be inser ted percutaneously and is ideally placed in the internal jugular vein. Although this catheter may be inser ted into the subclavian vein, the internal jugular is the preferred site. Contraindications: This catheter is intended for Long-Term vascular access only and should not be used for any purpose other than indicated in these instructions. To maintain peak performance, it is recommended that this catheter be replaced after 18 months usage. To maintain peak performance of the Lock right Adapters, it is recommended that the adapters be replaced every 6 months. TITAN HD Indications for Use: The Medcomp® Titan HD is indicated for use in attaining Long-Term vascular access for Hemodialysis and Apheresis. It may be inser ted percutaneously and is ideally placed in the internal jugular vein of an adult patient. Alternate inser tion sites includes the subclavian vein as required. Contraindications: This catheter is intended for Long-Term vascular access only and should not be used for any purpose other than indicated in these instructions. HEMO-FLOW® Indications for Use: The Medcomp® Hemo-Flow® Catheter is indicated for use in attaining Long-Term vascular access for Hemodialysis and Apheresis. It may be inser ted percutaneously and is primarily placed in the internal jugular vein. Alternate inser tion sites include the subclavian vein. Catheters greater than 40cm are intended for femoral vein inser tion. Contraindications: This catheter is intended for Long-Term vascular access only and should not be used for any purpose other than indicated in these instructions. HEMO-FLOW® XF Indications for Use: The Medcomp® Hemo-Flow® XF Catheter is indicated for use in attaining Long-Term vascular access for Hemodialysis and Apheresis. It may be inser ted percutaneously and is ideally placed in the internal jugular vein of an adult patient. Alternate inser tion site includes the subclavian vein as required. Contraindications: This catheter is intended for Long-Term vascular access only and should not be used for any purpose other than indicated in these instructions.
RkJQdWJsaXNoZXIy MTYyNDM3Mw==